A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy

NCT06085664 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Radical Prostatectomy

Interventions

DRUG: REGN5678
DRUG: Piflufolastat F18

Sponsor

M.D. Anderson Cancer Center